Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Gynecologic Oncology Group
ClinicalTrials.gov Identifier:
NCT00087126
First received: July 8, 2004
Last updated: May 29, 2015
Last verified: May 2015